The present disclosure pertains to medical devices, and methods for manufacturing and using medical devices. More particularly, the disclosure is directed to implantable medical devices having a visual indicator showing appropriate orientation during and after implantation.
A wide variety of medical devices have been developed for medical use, for example, for use in accessing body cavities and interacting with fluids and structures in body cavities. Some of these devices may include guidewires, catheters, pumps, motors, controllers, filters, grinders, needles, valves, and delivery devices and/or systems used for delivering such devices. These devices are manufactured by any one of a variety of different manufacturing methods and may be used according to any one of a variety of methods. Of the known medical devices and methods, each has certain advantages and disadvantages.
This disclosure provides design, material, manufacturing method, and use alternatives for medical devices. An example may be found in an implantable medical device adapted to be implanted at an implantation site within the vasculature, the implantable medical device capable of being implanted at the implantation site within the vasculature at more than one position relative to the implantation site. The implantable medical device includes an expandable frame that is adapted to expand from a collapsed configuration for delivery to an expanded configuration for deployment, and one or more radiopaque markers disposed relative to the expandable frame such that fluoroscopic imaging of the implantable medical device during deployment provides an indication of a position of the implantable medical device relative to the implantation site.
Alternatively or additionally, at least some of the one or more radiopaque markers may be positioned to provide an indication of an axial position of the implantable medical device relative to the implantation site via fluoroscopic imaging.
Alternatively or additionally, at least some of the one or more radiopaque markers may be positioned to provide an indication of a rotational position of the implantable medical device relative to the implantation site via fluoroscopic imaging.
Alternatively or additionally, at least some of the one or more radiopaque markers may include radiopaque marker bands that are crimped onto a portion of the expandable frame.
Alternatively or additionally, at least some of the one or more radiopaque markers may include radiopaque wires wrapped around a portion of the expandable frame.
Alternatively or additionally, at least some of the one or more radiopaque markers may include radiopaque sutures sewn around a portion of the expandable frame.
Another example may be found in a replacement cardiac valve adapted to be implanted within a native cardiac valve annulus, the replacement cardiac valve capable of being implanted in more than one position relative to the native cardiac valve annulus. The replacement cardiac valve includes an expandable frame that is adapted to expand from a collapsed configuration for delivery to an expanded configuration for deployment, and one or more radiopaque indicators disposed relative to the expandable frame such that fluoroscopic imaging of the replacement cardiac valve during deployment provides an indication of a position of the replacement cardiac valve relative to the native cardiac valve annulus. The expandable frame includes an annular portion adapted to engage the native cardiac valve annulus when deployed, a plurality of commissural posts adapted to extend above the native cardiac valve annulus when deployed, and a valve material secured relative to the plurality of commissural posts, with the valve material forming a valve cusp between each of the plurality of commissural posts.
Alternatively or additionally, at least some of the one or more radiopaque indicators may be adapted to provide an indication of insertion depth of the replacement cardiac valve relative to the native cardiac valve annulus.
Alternatively or additionally, at least some of the one or more radiopaque indicators may be secured relative to the annular portion of the expandable frame that is adapted to engage the native cardiac valve annulus when deployed.
Alternatively or additionally, at least some of the one or more radiopaque indicators may be adapted to provide an indication of relative rotational position of the replacement cardiac valve relative to the native cardiac valve annulus.
Alternatively or additionally, at least some of the one or more radiopaque indicators may be secured relative to at least some of the plurality of commissural posts.
Alternatively or additionally, the expandable frame may include a plurality of struts, and one or more of the plurality of struts are adapted to accommodate at least some of the one or more radiopaque indicators.
Alternatively or additionally, one or more of the plurality of struts may be formed with a narrowed portion adapted to accommodate a radiopaque marker band there about.
Alternatively or additionally, the expandable frame may include a plurality of loops, and one or more of the loops are adapted to accommodate one or more radiopaque indicators within at least some of the loops.
Another example may be found in an aortic valve adapted to be implanted within a native aortic valve annulus, the aortic valve capable of being implanted in more than one position relative to the native aortic valve annulus. The aortic valve includes an expandable frame that is adapted to expand from a collapsed configuration for delivery to an expanded configuration for deployment, and that includes an annular portion adapted to engage the native aortic valve annulus when deployed, a plurality of commissural posts adapted to extend above the native cardiac valve annulus when deployed, a plurality of stabilization arches adapted to extend above the plurality of commissural posts, and a valve material secured relative to the plurality of commissural posts, with the valve material forming a valve cusp between each of the plurality of commissural posts. A plurality of radiopaque indicators are disposed relative to the expandable frame such that fluoroscopic imaging of the aortic valve during deployment provides an indication of a position of the aortic valve relative to the native aortic valve annulus.
Alternatively or additionally, at least some of the plurality of radiopaque indicators may be adapted to provide an indication of insertion depth of the aortic valve relative to the native aortic valve annulus.
Alternatively or additionally, at least some of the plurality of radiopaque indicators may be secured relative to the annular portion of the expandable frame that is adapted to engage the native aortic valve annulus when deployed.
Alternatively or additionally, at least some of the plurality of radiopaque indicators may be adapted to provide an indication of relative rotational position of the aortic valve relative to the native aortic valve annulus.
Alternatively or additionally, at least some of the plurality of radiopaque indicators may be secured relative to at least some of the plurality of commissural posts.
Alternatively or additionally, at least some of the plurality of radiopaque indicators may be adapted to provide an indication of insertion depth of the aortic valve relative to the native aortic valve annulus and at least some of the plurality of radiopaque indicators are adapted to provide an indication of relative rotational position of the aortic valve relative to the native aortic valve annulus.
The above summary of some embodiments is not intended to describe each disclosed embodiment or every implementation of the present disclosure. The Figures, and Detailed Description, which follow, more particularly exemplify these embodiments.
The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:
While the disclosure is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the disclosure to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the disclosure.
For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.
The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.
A number of implantable medical devices are implanted at a variety of different implantation sites within a patient. In some cases, some implantable medical devices are capable of being implanted in more than one possible position at a particular implantation site. For example, some implantable medical devices, by basis of their configuration or overall shape, may be capable of being implanted in more than one axial position relative to the implantation site. If the implantation site is an annulus, for example, the implantable medical device may be capable of being implanted at differing penetration depths relative to the annulus. Some anatomies and/or physician's preferences may dictate a more proximal implantation position, or relatively less penetration depth. Some anatomies and/or physician's preferences may dictate a more distal implantation position, or a relatively greater penetration depth.
Some implantable medical devices, by basis of their configuration or overall shape, may be capable of being implanted in more than one rotational position relative to the implantation site. In some cases, an implantable medical device may be capable of being implanted at more than one axial position and more than one rotational position relative to the implantation site. With respect to rotational position, which may refer to a relative rotational orientation of the implantable medical device, the implantable medical device may be implanted such that a particular reference point on the implantable medical device, for example, may be facing any particular rotational point as defined along a 360 degree circle. The reference point may be facing a direction of 45 degrees, or perhaps 310 degrees, or any of a variety of different directions. For some implantable medical devices, the rotational position or orientation may not matter. For some implantable medical devices, the rotational position or orientation may be important.
For ease of illustration, the disclosure is directed to the implantable medical device being a replacement cardiac valve, such as a replacement aortic valve, that is deliverable in a trans-catheter manner. However, the disclosure is intended to not be so limited, as the replacement aortic valve described herein is merely illustrative.
The replacement cardiac valve 10 includes an expandable frame 12 that may be compressible to a radially compressed, or collapsed, configuration for delivery using a delivery catheter, and may be expandable to an expanded configuration (as shown) during implantation. The replacement cardiac valve 10 may include a plurality of leaflets defining a valve 14 (as seen in
In some cases, the expandable frame may include a lower tubular or crown portion 16, an upper crown portion 18, a plurality of upstanding commissural posts 20, and a plurality of stabilization arches 22. In use, the lower portion 16 of the expandable frame 12 may be adapted to be deployed after the other regions of the expandable frame 12. For example, the arches 22, the supports 20 and the upper crown 18 may be deployed at least partly before the lower portion 16 (in that order, or in reverse order, or in a different order). At the very least, once the upper crown 18 has been at least partly deployed, the expandable frame 12 may be urged and/or displaced in the direction of arrow 24 to seat the upper crown 18 against native leaflets at the implantation site. Deploying the lower portion 16 last fixes the expandable frame 12 in its final position.
The lower portion 16, and optionally a portion of the upper crown 18, may be formed by a lattice structure of the stent. The lattice structure may define cells or apertures, for example, generally diamond-shaped apertures. In some cases, the native leaflets may generally overlap a portion 26 of the expandable frame 12. The native valve annulus may overlap a portion 28 of the expandable frame. In some instances, the lower portion 16 may have an extremity formed with a substantially zig-zag shape. The zig-zag shape may include lower apexes 16a and upper apexes 16b. The upper apexes 16b may be masked in
The expandable frame 12 may optionally be of a self-expanding type that is compressible to the compressed configuration for loading into a delivery catheter for delivery to the site of implantation. In use, by removal of the constraining effect of a sheath holding the expandable frame 12 in the compressed configuration, the expandable frame 12 self-expands to or towards the operative configuration. A self-expanding stent may, for example, be of shape-memory material, for example, shape-memory metal alloy, for example, nitinol. Alternatively, the expandable frame 12 may be configured to be expanded by application of a foreshortening force from the delivery catheter and/or by application of expanding force from the delivery catheter, such as by using an expansion balloon. These are just examples.
In some cases, a physician may have a preference as to the axial position, or penetration depth, that they prefer for implantation of the replacement cardiac valve 10. In some instances, unique features of the patient's anatomy, such as but not limited to the particular anatomy of the patient's native cardiac annulus 30, or the sizing of the native valve cusps that are pushed to the side by the replacement cardiac valve 10, may suggest a particular axial position or penetration depth into the native cardiac annulus 30. Particular features of the patient's vasculature may dictate an optimal positioning for the stabilization arches 22. Any of a variety of different anatomical features may dictate an optimal axial position for the replacement cardiac valve 10 for a particular patient. As will be discussed, the replacement cardiac valve 10 may include features that allow for easy identification of the axial position, or penetration depth, of the replacement cardiac valve 10 during implantation. In some instances, the replacement cardiac valve 10 may include features that are visible via fluoroscopy.
In some cases, the relative rotational position or orientation of the replacement cardiac valve 10 may be important, particularly when the replacement cardiac valve 10 is a replacement aortic valve, intended for implantation within a native aortic annulus. In some cases, portions of the replacement cardiac valve 10 may potentially interfere with subsequent access to the coronary arteries. In some patients, particularly younger patients, there may be a subsequent need to implant a new replacement aortic valve some years after the initial implantation. In some patients, there may be a need, either immediate or down the road, to access one or more of the coronary arteries in order to perform angioplasty or rotational atherectomy, for example. There may be a need to access one or more of the coronary arteries in order to implant one or more stents. If the initially implanted replacement aortic valve interferes with access to the coronary arteries, this can be problematic.
As noted, implantable medical devices such as replacement cardiac valves may include features that allow fluoroscopic viewing of the relative axial and/or rotational positioning of the implantable medical devices.
In some cases, the radiopaque indicators or markers that are disposed along the line 70 may be vertically aligned with the commissural posts 58, for example, in which case the same radiopaque indicators or markers may indicate both axial positioning and rotational positioning of the replacement aortic valve 48 relative to the native aortic annulus 52. The replacement aortic valve 48 may be rotated, if necessary, for the radiopaque indicators or markers to appropriately align relative to the native aortic annulus 52 such that the expandable frame 54 does not interfere with access to the coronary arteries 44 and 46 (
The expandable frames 12, 38 and 54 may be formed in a variety of ways. In some cases, the expandable frames 12, 38 and 54 may be laser-cut from a Nitinol tube, for example.
In some cases, radiopaque sutures may be provided in or on other parts of a replacement aortic valve in order to provide radiopaque indicators.
The devices described herein, as well as various components thereof, may be manufactured according to essentially any suitable manufacturing technique including molding, casting, mechanical working, and the like, or any other suitable technique. Furthermore, the various structures may include materials commonly associated with medical devices such as metals, metal alloys, polymers, metal-polymer composites, ceramics, combinations thereof, and the like, or any other suitable material. These materials may include transparent or translucent materials to aid in visualization during the procedure. Some examples of suitable metals and metal alloys include stainless steel, such as 304V, 304L, and 316LV stainless steel; mild steel; nickel-titanium alloy such as linear-elastic and/or super-elastic nitinol; other nickel alloys such as nickel-chromium-molybdenum alloys (e.g., UNS: N06625 such as INCONEL® 625, UNS: N06022 such as HASTELLOY® C-22®, UNS: N10276 such as HASTELLOY® C276®, other HASTELLOY® alloys, and the like), nickel-copper alloys (e.g., UNS: N04400 such as MONEL® 400, NICKELVAC® 400, NICORROS® 400, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R30035 such as MP35-N® and the like), nickel-molybdenum alloys (e.g., UNS: N10665 such as HASTELLOY® ALLOY B2®), other nickel-chromium alloys, other nickel-molybdenum alloys, other nickel-cobalt alloys, other nickel-iron alloys, other nickel-copper alloys, other nickel-tungsten or tungsten alloys, and the like; cobalt-chromium alloys; cobalt-chromium-molybdenum alloys (e.g., UNS: R30003 such as ELGILOY®, PHYNOX®, and the like); platinum enriched stainless steel; combinations thereof; and the like; or any other suitable material.
Some examples of suitable polymers may include polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM, for example, DELRIN® available from DuPont), polyether block ester, polyurethane, polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example, ARNITEL® available from DSM Engineering Plastics), ether or ester based copolymers (for example, butylene/poly(alkylene ether) phthalate and/or other polyester elastomers such as HYTREL® available from DuPont), polyamide (for example, DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example available under the trade name PEBAX®), ethylene vinyl acetate copolymers (EVA), silicones, polyethylene (PE), Marlex high-density polyethylene, Marlex low-density polyethylene, linear low density polyethylene (for example REXELL®), polyester, polybutylene terephthalate (PBT), polyethylene terephthalate (PET), polytrimethylene terephthalate, polyethylene naphthalate (PEN), polyetheretherketone (PEEK), polyimide (PI), polyetherimide (PEI), polyphenylene sulfide (PPS), polyphenylene oxide (PPO), poly paraphenylene terephthalamide (for example, KEVLAR®), polysulfone, nylon, nylon-12 (such as GRILAMID® available from EMS American Grilon), perfluoro(propyl vinyl ether) (PFA), ethylene vinyl alcohol, polyolefin, polystyrene, epoxy, polyvinylidene chloride (PVdC), polycarbonates, ionomers, biocompatible polymers, other suitable materials, or mixtures, combinations, copolymers thereof, polymer/metal composites, and the like.
It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the disclosure. This may include, to the extent that it is appropriate, the use of any of the features of one example embodiment being used in other embodiments. The invention's scope is, of course, defined in the language in which the appended claims are expressed.
This application claims the benefit of priority of U.S. Provisional Application No. 63/408,210 filed Sep. 20, 2022, the entire disclosure of which is hereby incorporated by reference.
Number | Date | Country | |
---|---|---|---|
63408210 | Sep 2022 | US |